相关实验视频
Updated: Jul 1, 2025
10:56
Assays for the Degradation of Misfolded Proteins in Cells
Published on: August 28, 2016
12.0K
UBQLN2中的致病突变表现出不同的聚合倾向和神经毒性
Nathaniel Safren1,2, Thuy P Dao3, Harihar Milaganur Mohan4,5
1Department of Neurology, University of Michigan, Ann Arbor, MI, 48109-2200, USA. nathaniel.safren@gmail.com.
Scientific reports
|March 13, 2024
概括
UBQLN2蛋白中的致病突变可以导致神经退行性疾病,如ALS和FTD. 与一种特定突变不同,大多数UBQLN2突变不会将蛋白质聚合与神经毒性联系起来.
科学领域:
- 分子生物学分子生物学
- 神经科学是一个神经科学.
- 遗传学 遗传学 是一个
背景情况:
- UBQLN2蛋白对于降解容易聚合的蛋白质至关重要,这些蛋白质与神经退行性疾病有关.
- UBQLN2中的突变与X相关的骨髓缩侧面硬化症 (ALS) 和前性痴呆症 (FTD) 有关.
- 以前的研究表明,一种特定的突变 (P506T) 改变了UBQLN2的组装特性,并将聚合与神经毒性联系起来.
研究的目的:
- 研究各种与ALS/FTD相关的UBQLN2突变对蛋白质聚合,神经毒性,相分离和自流的影响.
- 确定UBQLN2聚合倾向与不同致病突变中的神经退行之间是否存在可概括的相关性.
主要方法:
- 对多个UBQLN2突变的系统评估.
- 评估聚合倾向,神经毒性,相分离和自相流量.
- 对突变效应的比较分析,以P506T突变为参考.
主要成果:
- 在大多数测试的致病性UBQLN2突变体中,没有观察到聚合倾向和神经毒性之间的明确相关性.
- 在研究的突变中,P506T突变在聚合和神经毒性之间的联系似乎是唯一的.
- 该研究强调了不同UBQLN2突变在神经退行症的背景下具有独特的性质.
结论:
- 这些发现表明,在ALS/FTD中UBQLN2聚合和神经退行之间可能不存在可概括的联系.
- 致病性UBQLN2突变表现出独特的效应,挑战了UBQLN2相关的神经退行性疾病的一致性模型.
相关概念视频
03:03Amyloid Fibrils
9.5K
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
9.5K
02:04Covalently Linked Protein Regulators
6.8K
Proteins can undergo many types of post-translational modifications, often in response to changes in their environment. These modifications play an important role in the function and stability of these proteins. Covalently linked molecules include functional groups, such as methyl, acetyl, and phosphate groups, and also small proteins, such as ubiquitin. There are around 200 different types of covalent regulators that have been identified.
These groups modify specific amino acids in a protein....
These groups modify specific amino acids in a protein....
6.8K